Search Results

Site Search

October 2023 - Clinical Microbiology - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Microbiology.

MCL Renal Biopsy Procedure for Handling Tissue for Light Microscopy Immunoflorescent Histology and Electron Microscopy MC123544

MCL Renal Biopsy Procedure Handling Tissue Light Microscopy Immunoflorescent Histology Electron Microscopy Renal Biopsy Procedure Handling Tissue Light Microscopy Immunofluorescent Histology Electron Microscopy Biopsy specimens typically...

lysosomal_storage_disorders_diagnostic_algorithm_part_2.pdf

If deficient, MLD confirmed One of the following suspected: ■ Aspartylglucosaminuria ■ α-Mannosidosis ■ β-Mannosidosis ■ Pompe disease ■ Sandhoff disease ■ Schindler disease ■ Sialidosis ■ Galactosialidosis* ■ α-Fucosidosis* ■...

MCL Second Trimester Maternal Screening AlphaFetoprotein Quad Screen Patient Information MC1235123

MCL Trimester Maternal Screening AlphaFetoprotein Quad Screen Patient Information Complete print Reset Form Trimester Maternal Screening Alpha Fetoprotein Quad Screen Patient Information Patient Information required Patient

search - Mayo Clinic Laboratories

Search Results Site Search...

laboratory_testing_for_infectious_causes_of_diarrhea.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. MCR 04/2025 Laboratory Testing for Infectious Causes of Diarrhea1 Community-acquired diarrhea, <7 days duration WITHOUT warning signs or risk factors for...

international-shipping-guide-french.pdf

G U ID E D ’EXPÉD ITIO N IN TERN ATIO N ALEENVOYER DES TESTS À LA MAYO CLINIC DEPUIS LE MONDE ENTIER 2 | GUIDE D’EXPÉDITION INTERNATIONALE TABLE DES MATIÈRES EXPÉDIER AUX ÉTATS-UNIS DEPUIS LE MONDE ENTIER 3 Avant...

MCL Whole Genome Sequencing Ordering Checklist MC1235301

MCL Genome Sequencing Ordering Checklist Complete print Genome Sequencing Ordering Checklist Reset Form Instructions Select box test requested

IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL) - Insights

In this month’s “Hot Topic,” Curtis Hanson, M.D., will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL). He will also highlight the importance of molecular analyses for IGHV and TP53...

Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 10 - Insights

This week’s Research Roundup highlights hepatocellular carcinoma detection by plasma methylated DNA through a discovery, phase I pilot, and phase II clinical validation.

Lysosomal metabolism and storage disorders - Insights

Learn more about how Mayo Clinic Laboratories’ comprehensive menu of biochemical and molecular testing can clarify diagnosis of a lysosomal metabolism and storage disorder.

MAG Antibody Testing [Test in Focus] - Insights

John Mills, Ph.D., explains Mayo Clinic Laboratories’ approach to MAG antibody testing. The ELISA-based assay uses higher reference ranges and human MAG antigen to detect MAG antibodies, which are associated with a rare, hard-to-treat...

Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D. - Insights

Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost...

Sarcoma Targeted Gene Panel [Test in Focus] - Insights

Andre Oliveira, M.D., Ph.D., gives an overview of this testing available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing compares to previous testing approaches, and what clinical action...

MCL Renal Diagnostics Test Request MC076711

MCL Renal Diagnostics Test Request Complete print Reset Form Renal Diagnostics Test Request Client Information required Client Patient Information required Patient ID Medical

Classical Hematology Conference - Insights

This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.

Classical Hematology Conference - Insights

This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.

Classical Hematology Conference - Insights

This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.

Classical Hematology Conference - Insights

This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.

Classical Hematology Conference - Insights

This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.

Classical Hematology Conference - Insights

This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.

Classical Hematology Conference - Insights

This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.

Classical Hematology Conference - Insights

This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.

Classical Hematology Conference - Insights

This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.

Classical Hematology Conference - Insights

This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.

lysosomal_storage_disorders_screen_interpretive_algorithm.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 04/2022 Lysosomal Storage Disorders Screen Interpretive Algorithm One of the following: ■ α-Mannosidosis ■ Aspartyglucosaminuria ■ β-Mannosidosis ■ Gaucher...

Diagnostic Exploratory Testing - Insights

In this month's "Hot Topic," Nicole Boczek, Ph.D., assistant professor and laboratory director in the Department of Laboratory Medicine and Pathology, and Sarah Barnett, M.S., CGC, discuss diagnostic exploratory testing, explain why it’s...

Industry Archives - Insights

Skip to Content MayoACCESS MayoLINK...

Week in Review Archives - Insights

Skip to Content MayoACCESS MayoLINK...

Research Roundup Archives - Page 4 of 29 - Insights

Skip to Content MayoACCESS MayoLINK...

Research Archives - Page 4 of 33 - Insights

Skip to Content MayoACCESS MayoLINK...

National Stop The Bleed Day - Insights

Pat Hlavka, CSP, Safety Coordinator at Mayo Clinic, talks about the importance of National Stop The Bleed Day, a national awareness campaign about the top cause of preventable death in trauma.

July 2023 - Cytopathology and Pulmonary Pathology - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Cytopathology & Pulmonary Pathology.

November 2023 - Laboratory Genetics and Genomics - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Laboratory Genetics and Genomics.

Mayo Clinic Laboratory and Pathology Research Roundup: Dec. 4 - Insights

This week’s Research Roundup highlights extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy.

Membranous nephropathy - Insights

Membranous nephropathy (MN) is one of the leading causes of nephrotic syndrome in adults. Our menu of clinically validated assays assists with diagnosis, monitors disease progression, and guides clinical outcomes.

Chromosomal microarray better informs brain tumor diagnosis - Insights

Molecular biomarkers are a critical component in the treatment of adult and pediatric brain tumors. Robert Jenkins, M.D., Ph.D., explains how Mayo Clinic Laboratories' chromosomal microarray provides more comprehensive and accurate tumor...

Multiple Sclerosis Profile Updates - Insights

Maria Alice Willrich, Ph.D., explains kappa free light chain testing — Mayo Clinic Laboratories' data-driven approach to diagnose multiple sclerosis. The automated assay is more sensitive, cost-effective, and faster than traditional...

Paraneoplastic Vision Loss Evaluation [Test in Focus] - Insights

Andrew McKeon, M,B., B.Ch., M.D., provides an overview of Mayo Clinic Laboratories' new paraneoplastic vision loss evaluation — a test that can help direct a cancer diagnosis and guide treatment. He reviews why this test was developed, when...

Minimal residual disease - Insights

Get full-spectrum minimal residual disease testing options, all from one laboratory, with experts to support testing decisions and results.

Testing Archives - Page 21 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Labor Day Specimen Shipping Guidelines and Schedule - Insights

Mayo Clinic Laboratories specimen pickup and delivery schedules will be altered due to the upcoming holiday. To ensure specimen stability and prevent delays, follow these guidelines.

Colorectal panel provides detailed cancer information - Insights

Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new colorectal cancer panel. The assay covers more genes to better inform decision-making about prognosis, targeted therapies and a hereditary cancer syndrome.

Extended Spectrum Beta Lactamase Testing - Insights

Audrey Schuetz, M.D., provides a detailed overview of Mayo Clinic Laboratories’ new culture-based extended spectrum beta lactamase (ESBL) testing. Used to screen for the presence of multi-drug resistant gram-negative bacteria in donor stool...

Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score - Insights

In this month’s “Hot Topic,” Divyanshu Dubey, M.B.B.S., discusses how patients with encephalopathy and/or epilepsy of unknown etiology may have an autoimmune or paraneoplastic cause.

Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score - Insights

In this month’s “Hot Topic,” Divyanshu Dubey, M.B.B.S., discusses how patients with encephalopathy and/or epilepsy of unknown etiology may have an autoimmune or paraneoplastic cause.

CPT Codes and LOINC Update: September 2020 - Insights

The following list includes updates posted to mayocliniclabs.com during the month of September

lysosomal-disorders-screen-interpretive.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 12/2024 Lysosomal Disorders Screen Interpretive Algorithm One of the following: ■ α-Mannosidosis ■ Aspartyglucosaminuria ■ β-Mannosidosis ■ Gaucher disease ■...